Syndax Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 8.63 M | $132.70 M | -17.52% | 9.99% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 8.52 M | $131.08 M | 0.00% | 9.87% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 5.49 M | $84.41 M | -5.36% | 6.35% |
| VANGUARD GROUP INC | 11/07/2025 | 5.14 M | $79.06 M | 2.08% | 5.95% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 4.26 M | $65.46 M | 100.01% | 4.93% |
| STATE STREET CORP | 11/14/2025 | 3.85 M | $59.29 M | 11.93% | 4.46% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.70 M | $56.89 M | -3.68% | 4.28% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 3.47 M | $53.34 M | -14.71% | 4.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 3.31 M | $50.95 M | 131.21% | 3.84% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 2.50 M | $38.46 M | 19.05% | 2.90% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.39 M | $36.78 M | 1.31% | 2.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.09 M | $32.18 M | 2.05% | 2.42% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 2.01 M | $30.96 M | 84.24% | 2.33% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 1.78 M | $27.45 M | -12.54% | 2.07% |
| UBS GROUP AG | 11/13/2025 | 1.67 M | $25.76 M | 16.66% | 1.94% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 1.64 M | $25.31 M | -1.26% | 1.91% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 1.61 M | $24.84 M | -23.27% | 1.87% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.55 M | $23.85 M | -18.08% | 1.80% |
| NUVEEN, LLC | 11/12/2025 | 1.48 M | $22.71 M | 454.72% | 1.71% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 1.38 M | $21.16 M | 100.00% | 1.59% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 1.37 M | $21.02 M | -42.42% | 1.58% |
| AISLING CAPITAL MANAGEMENT LP | 11/12/2025 | 1.32 M | $20.27 M | 0.00% | 1.53% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 1.24 M | $19.02 M | -14.48% | 1.43% |
| MORGAN STANLEY | 11/14/2025 | 1.20 M | $18.45 M | 41.22% | 1.39% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.08 M | $16.58 M | 67.19% | 1.25% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.05 M | $16.19 M | 343.83% | 1.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.05 M | $16.10 M | -34.54% | 1.21% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 1.00 M | $15.44 M | -7.06% | 1.16% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 988.49 K | $15.21 M | -30.10% | 1.14% |
| ALGERT GLOBAL LLC | 11/14/2025 | 930.77 K | $14.32 M | -8.86% | 1.08% |
| CANDRIAM S.C.A. | 11/06/2025 | 925.33 K | $14.24 M | 37.07% | 1.07% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 860.50 K | $13.24 M | 2.72% | 1.00% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 846.90 K | $13.03 M | -2.41% | 0.98% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 809.06 K | $12.45 M | 17.41% | 0.94% |
| NORTHERN TRUST CORP | 11/14/2025 | 776.69 K | $11.95 M | 0.81% | 0.90% |
| JANE STREET GROUP, LLC | 11/14/2025 | 738.27 K | $11.36 M | 340.77% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 719.03 K | $11.06 M | 0.94% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 712.66 K | $10.96 M | 27.95% | 0.83% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 654.93 K | $10.08 M | 47.38% | 0.76% |
| APIS CAPITAL ADVISORS, LLC | 11/14/2025 | 638.00 K | $9.82 M | 100.00% | 0.74% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 618.80 K | $9.52 M | 26.57% | 0.72% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 599.87 K | $9.23 M | 20.00% | 0.69% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 574.00 K | $8.83 M | 0.00% | 0.66% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 558.08 K | $8.59 M | 142.03% | 0.65% |
| CITADEL ADVISORS LLC | 11/14/2025 | 546.27 K | $8.40 M | -14.65% | 0.63% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 500.70 K | $7.70 M | -7.89% | 0.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 463.71 K | $7.13 M | 15.07% | 0.54% |
| KNOTT DAVID M JR | 11/12/2025 | 428.00 K | $6.58 M | 21.32% | 0.50% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 413.00 K | $6.36 M | 144.81% | 0.48% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 396.34 K | $6.10 M | -60.02% | 0.46% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Syndax Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 291 institutional investors and hedge funds held shares of Syndax Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 8.63 M
Kynam Capital Management, LP: 8.52 M
GOLDMAN SACHS GROUP INC: 5.49 M
VANGUARD GROUP INC: 5.14 M
Point72 Asset Management, L.P.: 4.26 M
STATE STREET CORP: 3.85 M
117.31% of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 112.26 M shares in the last 24 months. This purchase volume represents approximately $2.22 B in transactions.